Characterization of Magnetic Steels for the FCC-ee Magnet Prototypes

At the European Organization for the Nuclear Research (CERN), several efforts were combined for a preliminary design of a new accelerator, the Future Circular Collider (FCC), a 100-TeV double-ring hadron collider to be installed in a 100-km tunnel. As potential intermediate step, a high-luminosity lepton collider called FCC-ee is foreseen with more than 9,000 magnets. This paper provides an insight into the magnetic properties of the steels, potentially considered for the new dipole magnets, with nominal field of only 56 mT. The influence of the properties of these steels on the magnet transfer function has been assessed analytically using an equivalent reluctance network to model the first 1-m long dipole prototypes. The analytical results were validated experimentally. The proposed approach can be a useful tool for traceability and quality control during the series production

TLR-4 and VEGF polymorphisms in chronic periaortitis

Chronic periaortitis (CP) is a rare disease that is characterised by fibro-inflammatory tissue surrounding the abdominal aorta and has both non-aneurysmal (idiopathic retroperitoneal fibrosis [IRF]) and aneurysmal forms (inflammatory abdominal aortic aneurysm [IAAA]). We investigated whether toll-like receptor 4 (TLR-4) and vascular endothelial growth factor (VEGF) polymorphisms were associated with susceptibility to, and the clinical features of CP

Performance of LHC Main Dipoles for Beam Operation

At present about 90% of the main dipoles for the LHC have been manufactured and one of the three cold mass assemblers has already completed the production. 85% of the 1232 dipoles needed for the tunnel have been tested and accepted. In this paper we mainly deal with the performance results: the quench behaviour, the magnetic field quality, the electrical integrity quality and the geometry features will be summarized

Retroperitoneal fibrosis

Retroperitoneal fibrosis encompasses a range of diseases characterised by the presence of a fibro-inflammatory tissue, which usually surrounds the abdominal aorta and the iliac arteries and extends into the retroperitoneum to envelop neighbouring structures--eg, ureters. Retroperitoneal fibrosis is generally idiopathic, but can also be secondary to the use of certain drugs, malignant diseases, infections, and surgery. Idiopathic disease was thought to result from a local inflammatory reaction to antigens in the atherosclerotic plaques of the abdominal aorta, but clinicolaboratory findings--namely, the presence of constitutional symptoms and the high concentrations of acute-phase reactants--and the frequent association of the disease with autoimmune diseases that involve other organs suggest that it might be a manifestation of a systemic autoimmune or inflammatory disease. Steroids are normally used to treat idiopathic retroperitoneal fibrosis, although other options--eg, immunosuppressants, tamoxifen--are available. The outlook is usually good, but, if not appropriately diagnosed or treated, the disease can cause severe complications, such as end-stage renal failure. Here, we review the different aspects of retroperitoneal fibrosis, focusing on idiopathic retroperitoneal fibrosis and on the differential diagnosis associated with the secondary forms